Prof. Jianhua Chen 陈建华
Chief Physician, Professor
Department of Medical Oncology, Hunan Cancer Hospital, Changsha
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Medical oncology for thoracic tumors, especially lung cancer. Focuses on chemotherapy, targeted therapy, immunotherapy, and biological therapy. Experienced in developing comprehensive treatment plans for advanced lung cancer.
Dr. Chen has worked in medical oncology since 1986 and holds a master's degree. The doctor serves as Chief of the First Thoracic Internal Medicine Department at Hunan Cancer Hospital and leads the hospital's lung cancer MDT team. Research interests include gene-guided targeted therapy and maintenance therapy for non-small cell lung cancer. Dr. Chen has visited France and the US for training, authored a textbook, and published over 40 papers.
Professional roles
- Council Member, Chinese Society of Clinical Oncology (CSCO)
- Committee Member, CSCO Vascular Targeted Therapy Expert Committee
- Committee Member, Lung Cancer Professional Committee, China Anti-Cancer Association
- Chair, Thoracic Internal Medicine Group, Oncology Professional Committee, Hunan Medical Association
Name order: in Chinese the family name comes first (Chen Jianhua). Papers usually list the name as Jianhua Chen or Chen J.
Selected publications
82 papers on PubMed matched by name and affiliation; 8 as first or senior author since 2016. Most recent first- or senior-author papers:
- Cancers (Basel), 2022 (senior author): A Novel Risk Score Model of Lactate Metabolism for Predicting over Survival and Immune Signature in Lung Adenocarcinoma. PubMed 35954390
- Zhongguo Fei Ai Za Zhi, 2022 (senior author): [Anti-angiogenesis in Lung Cancer: Current Situation, Progress and Confusion]. PubMed 35477192
- Zhongguo Fei Ai Za Zhi, 2020 (senior author): [Clinical Analysis of Primary Pulmonary Lymphoepithelioma-like Carcinoma in 8 Patients]. PubMed 32209185
- Oncol Lett, 2019 (senior author): Comprehensive analysis of genomic alterations detected by next-generation sequencing-based tissue and circulating tumor DNA assays in Chinese patients with non-small cell lung cancer. PubMed 31611986
- Oncol Lett, 2018 (first author): Clinical application of plasma mitochondrial DNA content in patients with lung cancer. PubMed 30546441
- Mol Med Rep, 2018 (first author): Inhibition of autophagy promotes cisplatin-induced apoptotic cell death through Atg5 and Beclin 1 in A549 human lung cancer cells. PubMed 29512762
- Open Med (Wars), 2018 (senior author): Effectiveness of Treatment with Endostatin in Combination with Emcitabine, Carboplatin, and Gemcitabine in Patients with Advanced Non-small Cell Lung Cancer: A Retrospective Study. PubMed 29696151
- Zhongguo Fei Ai Za Zhi, 2017 (senior author): [Four Cases Report on Primary Lung Adenoid Cystic Carcinoma]. PubMed 29167011
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion